Neurofibromatosis type 1; a survey of 196 patients;Neurofibromatosis type 1; een overzicht van 196 patienten

Nederlands Tijdschrift voor Geneeskunde

Volumn 141, Issue 13, 1997, Pages 624-629

  Overweg Plandsoen, W C G ^a   Weersink, R G M ^a   Sillevis Smitt, J H ^a   Fleury, P ^a   Van Asperen, C J ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BLOOD PRESSURE MEASUREMENT; CHILD; CLINICAL FEATURE; DISEASE SEVERITY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROFIBROMATOSIS; SYMPTOM;

ADOLESCENT; ADULT; CAFE-AU-LAIT SPOTS; CHILD; CRANIAL NERVE NEOPLASMS; EYE DISEASES; GLIOMA; HUMANS; KYPHOSIS; MEDICAL HISTORY TAKING; NEUROFIBROMATOSIS 1; NEUROLOGIC EXAMINATION; OPTIC NERVE DISEASES; PHYSICAL EXAMINATION; RENAL ARTERY OBSTRUCTION; RETROSPECTIVE STUDIES; SCOLIOSIS;

EID: 0030909031     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Neurofibromatosis. Conference statement. National Institutes of Health Consensus Development Conference. Arch Neurol 1988;45: 575-8.
2. Fleury P. Neurofibromatosis; genetische en klinische aspecten. Ned Tijdschr Geneeskd 1989;133:2279-83.
3. Riccardi VM. Neurofibromatosis. Phenotype, natural history and pathogenesis. 2nd ed. Baltimore: Johns Hopkins University Press, 1992.
4. Huson SM, Hughes RAC, editors. The neurofibromatoses, a pathogenetic and clinical overview. 1st ed. London: Chapman & Hall, 1994.
5. Hulsebos TJM. Moleculair-genetische aspecten van neurofibromatosis. Ned Tijdschr Geneeskd 1997;141:620-3.
6. Shen MH, Harper PS, Upadhyaya M. Molecular genetics of neurofibromatosis type 1. J Med Genet 1996;33:2-17.
7. Altman DG. Practical statistics for medical research. London: Chapman & Hall, 1991.
8. Pryor HB. Objective measurement of interpupillary distance. Pediatrics 1969;44:973-7.
9. Allanson JE, Hall JG, Van Allen MI. Noonan phenotype associated with neurofibromatosis. Am J Med Genet 1985;21:457-62.
10. Cole TRP, Dennis NR, Hughes HE. Weaver syndrome. J Med Genet 1992;29:332-7.
11. Huson SM, Compston DAS, Clark P, Harper PS. A genetic study of von Recklinghausen neurofibromatosis in south east Wales. I. Prevalence, fitness, mutation rate, and effect of parental transmission on severity. J Med Genet 1989;26:704-11.
12. North K. Neurofibromatosis type 1: review of the first 200 patients in an Australian clinic. J Child Neurol 1993;8:395-402.
13. Listernick R, Charrow J, Greenwald M, Mets M. Natural history of optic pathway tumors in children with neurofibromatosis type 1: a longitudinal study. J Pediatr 1994;125:63-6.
14. Kuenzle Ch, Weissert M, Roulet E, Bode H, Schefer S, Huisman Th, et al. Follow-up of optic pathway gliomas in children with neurofibromatosis type 1. Neuropediatrics 1994;25:295-300.
15. Duffner PK, Cohen ME, Seidel FG, Shucard DW. The significance of MRI abnormalities in children with neurofibromatosis. Neurology 1989;39:373-8.
16. Moore BD, Slopis JM, Schomer D, Jackson EF, Levy BM. Neuropsychological significance of areas of high signal intensity on brain MRIs of children with neurofibromatosis. Neurology 1996;46:1660-8.
17. Ferner RE, Hughes RAC, Weinman J. Intellectual impairment in neurofibromatosis 1. J Neurol Sci 1996;138:125-33.
18. North K, Joy P, Yuille D, Cocks N, Hutchins P. Cognitive function and academic performance in children with neurofibromatosis type 1. Dev Med Child Neurol 1995;37:427-36.
19. Huson SM, Compston DAS, Harper PS. A genetic study of von Recklinghausen neurofibromatosis in south east Wales. II. Guidelines for genetic counselling. J Med Genet 1989;26:712-21.
20. Sevick RJ, Barkovich AJ, Edwards MSB, Koch T, Berg B, Lempert T. Evolution of white matter lesions in neurofibromatosis type 1: MR findings. Am J Roentgenol 1992;159:171-5.